Titlebook: Biological Response Modifiers in Human Oncology and Immunology; Thomas Klein,Steven Specter,Andor Szentivanyi Book 1983 The Editor(s) (if

Dna262

T. Nickl-Jockschat,F. Schneiderhanges of in vivo and in vitro immune parameters after short-term oral administration of C 1821 in untreated cancer patients. In this small series of patients, no significant modifications of peripheral blood natural killer (NK) activity and lymphocyte subpopulation distribution were observed both a

Tidious

https://doi.org/10.1007/978-3-642-54571-90.5 to 1.0 mg/person/day once or twice a week in combination with chemotherapeutic agents for patients with advanced or recurrent cancer. In order to clarify the clinical efficacy of lentinan administration a Phase III randomized control trial has been conducted on patients with advanced or recurren

GRIN

Blatant

Monoclonal Antibodies as Anticancer Agentse in cancer biology. Since most of the monoclonal antibodies developed against human tumor cells have been made in mice by immunizing the mouse with human tumor cells or extracts thereof, these monoclonals are mouse immunoglobulins and represent the way a mouse cell sees a human tumor cell. While th

松果

Immune Response in Strain 2 Guinea Pigs to the Syngeneic L2C Leukemiauinea pigs when immunized with Ia. L2C tumor cells in adjuvant, but not generally with Ia. L2C tumor cells (3). However, immunization with Ia. L2C cells protects the strain 2 guinea pigs against any of the 5 sublines. The latter finding supports the early observations made by Gross (5) that some str

不可磨滅

Diminished Synthesis of Immunoglobulins by Lymphocytes of Patients Treated with Thymosin (TFX) and Cion (15). We have recently shown that TFX is a potent inducer of helper T cells for antibody production in man. However, when TFX is added to lymphocytes generating high numbers of plasma cells in culture the resulting immunoglobulin synthesis is markedly reduced (7, 8). This data indicates that in

遺棄

Metastasis

勉勵(lì)

Immunomodulating Effects of a Short-Term Oral Treatment with C 1821 in Untreated Cancer Patients: A hanges of in vivo and in vitro immune parameters after short-term oral administration of C 1821 in untreated cancer patients. In this small series of patients, no significant modifications of peripheral blood natural killer (NK) activity and lymphocyte subpopulation distribution were observed both a

Ophthalmologist